Monopar Therapeutics (MNPR) P/E (2019 - 2026)
Monopar Therapeutics (MNPR) P/E from Dec 19, 2019 to Jul 21, 2026. The TTM Monopar Therapeutics (MNPR) P/E is -49.95. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Monopar Therapeutics (MNPR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -49.95 | +62.28% |
| 2025 | -30.78 | +336.14% |
| 2024 | -7.06 | +1359.17% |
| 2023 | -0.48 | -83.44% |
| 2022 | -2.92 | -34.23% |
| 2021 | -4.44 | -58.88% |
| 2020 | -10.80 | -71.36% |
| 2019 | -37.69 | N/A |
Comparison Monopar Therapeutics (MNPR) P/E with competitors
Monopar Therapeutics (MNPR) P/E is -49.95.